Literature DB >> 13100413

Discussion on the chemotherapy of the reticuloses.

J F WILKINSON, A HADDOW, J D NABARRO.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; LYMPHOMA/therapy

Mesh：

Substances：

Year:  1953        PMID： 13100413      PMCID： PMC1918650     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

2.  Folic acid.

Authors:  J F WILKINSON
Journal:  Br Med J       Date:  1948-04-24

3.  Nitrogen mustard therapy with special reference to Hodgkin's disease.

Authors:  J D N NABARRO
Journal:  Br Med J       Date:  1949-09-17

4.  Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.

Authors:  C GARDIKAS; J F WILKINSON
Journal:  Lancet       Date:  1951-01-20       Impact factor: 79.321

5.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

6.  Treatment of acute leukemia with aminopterin.

Authors:  J F WILKINSON; C GARDIKAS
Journal:  Lancet       Date:  1951-02-10       Impact factor: 79.321

7.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962

8.  Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial.

Authors:  E PATERSON; J BOLAND
Journal:  Br J Cancer       Date:  1951-03       Impact factor: 7.640
  8 in total
  8 in total

1.  Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.

Authors:  A M BARLOW; J T LEEMING; J F WILKINSON
Journal:  Br Med J       Date:  1959-08-22

2.  [Long-term chemotherapy of chronic myeloid leukemia with Myleran and C69].

Authors:  H EHRHART
Journal:  Klin Wochenschr       Date:  1962-06-15

3.  Breast cancer; a new approach to therapy.

Authors:  G W WATSON; R L TURNER
Journal:  Br Med J       Date:  1959-05-23

4.  Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.

Authors:  L F LARIONOV
Journal:  Br Med J       Date:  1956-02-04

5.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

6.  Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Authors:  F G HAYHOE; D KOK
Journal:  Br Med J       Date:  1957-12-21

7.  The present status of radiotherapy and chemotherapy in the treatment of chronic leukaemia; a review.

Authors:  M HULBERT
Journal:  Postgrad Med J       Date:  1954-02       Impact factor: 2.401

8.  Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse.

Authors:  F J ROE; M H SALAMAN
Journal:  Br J Cancer       Date:  1955-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.